for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Laboratory Corp. of America Holdings

LH

Latest Trade

128.71USD

Change

-8.34(-6.09%)

Volume

1,058,667

Today's Range

126.36

 - 

133.29

52 Week Range

98.02

 - 

196.36

As of on the New York Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
137.05
Open
131.87
Volume
1,058,667
3M AVG Volume
20.26
Today's High
133.29
Today's Low
126.36
52 Week High
196.36
52 Week Low
98.02
Shares Out (MIL)
97.30
Market Cap (MIL)
12,523.48
Forward P/E
--
Dividend (Yield %)
--

Next Event

Q1 2020 Laboratory Corporation of America Holdings Earnings Release

Latest Developments

More

Hologic - U.S. FDA-Issuing Emergency Use Authorizations To Hologic For Its Panther Fusion Sars-Cov-2 Assay

Labcorp Launches Test For Coronavirus Disease 2019 (Covid-19)

Labcorp Announces Q4 Earnings Per Share $2.32

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Laboratory Corp. of America Holdings

Laboratory Corporation of America Holdings is a life sciences company that is integrated in guiding patient care, providing clinical laboratory and end-to-end drug development services. The Company operates as a healthcare diagnostics company. The Company operates through two segments: LabCorp Diagnostics (LCD) and Covance Drug Development (CDD). The LCD segment is an independent clinical laboratory business, which offers menu of frequently requested and specialty testing through an integrated network of primary and specialty laboratories across the United States. The CDD segment offers drug development services, and provides a range of drug research and development (R&D) and market access services to biopharmaceutical companies and medical device companies across the world. It serves a range of customers, including managed care organizations (MCOs), biopharmaceutical companies, governmental agencies, physicians and other healthcare providers.

Contact Info

358 S MAIN ST

BURLINGTON, NC

27215-5837

United States

+1.336.2291127

https://www.labcorp.com

Executive Leadership

Adam H. Schechter

President, Chief Executive Officer, Director

Glenn A. Eisenberg

Chief Financial Officer, Executive Vice President

Paul R Kirchgraber

Chief Executive Officer - Covance

Lisa J. Uthgenannt

Chief Human Resource Officer, Senior Vice President

Brian J. Caveney

Executive Vice President, President of Diagnostics

Key Stats

2.24 mean rating - 17 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2017

10.2K

2018

11.3K

2019

11.6K

2020(E)

12.0K
EPS (USD)

2017

9.600

2018

11.020

2019

11.320

2020(E)

11.876
Price To Earnings (TTM)
15.36
Price To Sales (TTM)
1.08
Price To Book (MRQ)
1.65
Price To Cash Flow (TTM)
8.93
Total Debt To Equity (MRQ)
83.32
LT Debt To Equity (MRQ)
77.72
Return on Investment (TTM)
5.56
Return on Equity (TTM)
4.82

Latest News

Latest News

BRIEF-Hologic - U.S. FDA-Issuing Emergency Use Authorizations To Hologic For Its Panther Fusion Sars-Cov-2 Assay

* U.S. FDA-ISSUING EMERGENCY USE AUTHORIZATIONS TO HOLOGIC FOR ITS PANTHER FUSION SARS-COV-2 ASSAY

LabCorp makes coronavirus test available for ordering in U.S.

Diagnostics company Laboratory Corp of America Holdings said on Thursday it will make its coronavirus test available for ordering by healthcare providers from 6 p.m. ET, as the U.S. government ramps up efforts to increase diagnostic capabilities.

LabCorp to make coronavirus test available for ordering in U.S.

Diagnostics company Laboratory Corp of America Holdings said on Thursday it plans to make its test for the new coronavirus available for ordering by healthcare providers in the United States from 6 p.m. ET.

Former FDA chief tells Labcorp, Quest Diagnostics to "step up" amid coronavirus outbreak

Laboratory Corp of America Holding <LH.N> and Quest Diagnostics Inc <DGX.N> should conduct tests for coronavirus in the country, former Food & Drug Administration commissioner Scott Gottlieb tweeted https://bit.ly/2PMXwWn on Wednesday.

LabCorp begins work on developing coronavirus test

LabCorp said on Thursday it has begun work on developing its own test for the coronavirus that has killed over 1,300 in China.

BRIEF-Labcorp Announces Q4 Earnings Per Share $2.32

Laboratory Corporation of America Holdings:

Pennsylvania insurer, LabCorp defeat lawsuit by rival lab

A federal judge has dismissed a lawsuit by a lab-testing company alleging that a health insurer and Laboratory Corporation of America Holdings worked to eliminate competition for the testing of sexually transmitted diseases in parts of Pennsylvania.

BRIEF-Eurofins Scientific Acquires LabCorp's Food Testing And Consulting Business

* ACQUISITION OF LABCORP’S FOOD TESTING AND CONSULTING BUSINESS

LabCorp's Covance business powers quarterly profit beat; shares rise

Laboratory Corp of America Holdings <LH.N> posted a quarterly profit on Wednesday that beat analysts' estimates, helped by higher demand at the unit performing clinical trials for drugmakers, and prompting the company to raise its full-year revenue target.

BRIEF-LabCorp Reports Q1 Earnings Per Share $1.67

Laboratory Corporation of America Holdings:

LabCorp quarterly profit falls 5.4 pct

Diagnostics testing company Laboratory Corp of America Holdings reported a 5.4 percent fall in quarterly profit on Wednesday, hurt by higher expenses.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up